Chair, Audit Committee
Chris Nolet has served as a director since July 2019 and is Chair of the Audit Committee. Mr. Nolet is a retired audit partner at Ernst & Young. In addition to serving clients, his responsibilities include leading the West EY Life Sciences Industry Group and serving as a member of the Global EY Life Sciences Executive Leadership Group, which establishes policies and operating strategies for EY’s $2 billion practice worldwide. He serves on both the Executive Committee and Audit Committee (Chair) of the California Life Sciences Industry Association (CSLA) for the past 18 years and is a former member of the Finance & Investment Committee and Emerging Companies Section of BIO (the Biotechnology Innovation Organization). Additionally, Mr. Nolet serves as a Board Member and Chair of the Audit Committee at Jasper Therapeutics (NASDAQ – JSPR). Mr. Nolet is a featured speaker at the annual Davis Polk IPO conference and has testified before congress regarding the need for FDA reform. He is a CPA (California) and member of the AIPCA and the California Society of CPAs. Additionally, Mr. Nolet served on the School of Accountancy Advisory Board at his alma mater San Diego State University.